AstraZeneca Pharma India Statistics
Total Valuation
AstraZeneca Pharma India has a market cap or net worth of INR 172.66 billion. The enterprise value is 167.65 billion.
Market Cap | 172.66B |
Enterprise Value | 167.65B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | Jul 5, 2024 |
Share Statistics
AstraZeneca Pharma India has 25.00 million shares outstanding. The number of shares has decreased by -0.03% in one year.
Shares Outstanding | 25.00M |
Shares Change (YoY) | -0.03% |
Shares Change (QoQ) | -0.09% |
Owned by Insiders (%) | 7.93% |
Owned by Institutions (%) | 7.23% |
Float | 4.16M |
Valuation Ratios
The trailing PE ratio is 180.07.
PE Ratio | 180.07 |
Forward PE | n/a |
PS Ratio | 12.44 |
PB Ratio | 24.25 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 174.89 |
EV / Sales | 12.08 |
EV / EBITDA | 106.94 |
EV / EBIT | 117.94 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.64 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 122.53 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 13.54% |
Revenue Per Employee | 14.76M |
Profits Per Employee | 1.02M |
Employee Count | 940 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.64% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +52.64% |
50-Day Moving Average | 6,763.11 |
200-Day Moving Average | 5,879.37 |
Relative Strength Index (RSI) | 55.06 |
Average Volume (20 Days) | 971 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AstraZeneca Pharma India had revenue of INR 13.88 billion and earned 958.60 million in profits. Earnings per share was 38.35.
Revenue | 13.88B |
Gross Profit | 6.67B |
Operating Income | 1.42B |
Pretax Income | 1.33B |
Net Income | 958.60M |
EBITDA | 1.54B |
EBIT | 1.42B |
Earnings Per Share (EPS) | 38.35 |
Balance Sheet
The company has 5.06 billion in cash and 45.90 million in debt, giving a net cash position of 5.01 billion or 200.39 per share.
Cash & Cash Equivalents | 5.06B |
Total Debt | 45.90M |
Net Cash | 5.01B |
Net Cash Per Share | 200.39 |
Equity (Book Value) | 7.12B |
Book Value Per Share | 284.77 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 48.06%, with operating and profit margins of 10.24% and 6.91%.
Gross Margin | 48.06% |
Operating Margin | 10.24% |
Pretax Margin | 9.58% |
Profit Margin | 6.91% |
EBITDA Margin | 11.07% |
EBIT Margin | 10.24% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.35%.
Dividend Per Share | 24.00 |
Dividend Yield | 0.35% |
Dividend Growth (YoY) | 50.00% |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | 0.03% |
Shareholder Yield | 0.38% |
Earnings Yield | 0.56% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 15, 2006. It was a forward split with a ratio of 5.
Last Split Date | Jun 15, 2006 |
Split Type | Forward |
Split Ratio | 5 |